搜索筛选:
搜索耗时0.0874秒,为你在为你在102,285,761篇论文里面共找到 5 篇相符的论文内容
发布年度:
Predictions about probabilities of adverse events and appropriate dose of roflumilast for Chinese CO
[会议论文] 作者：Xinge Cui,Xin Zheng,Pei Hu,Ji Jiang,
来源：第五届定量药理学与新药评价国际会议 年份：2015
...
Predictions about probabilities of adverse events and appropriate dose of roflumilast for Chinese CO
[会议论文] 作者：Xinge Cui,Xin Zheng,Pei Hu,Ji Jiang,
来源：第五届定量药理学与新药评价国际会议 年份：2015
Backgrounds: Roflumilast is an oral inhibitor of phosphodiesterase 4(PDE4), which is mainly metabolized by CYP3A4 and CYP1A2.The main metabolite of it is roflumilast N-oxide, which contributes to the...
[会议论文] 作者：Li YANG,Min LI,Xinge CUI,Yu BAI,Huwei LIU,
来源：BCEIA2013第十五届北京分析测试学术报告会(分析仪器应用技术报告会) 年份：2013
...
[会议论文] 作者：Li Yang,Xinge Cui,Min Li,Huwei Liu,Ningning Zhang,Xiaohong Han,Yu Bai,Yuankai Shi,
来源：43rd International Symposium on High Performance Liquid Phas 年份：2015
...
[会议论文] 作者：Huwei Liu,Li Yang,Xinge Cui,Ningning Zhang,Min Li,Yu Bai,Xiaohong Han,Yuankai Shi,
来源：43rd International Symposium on High Performance Liquid Phas 年份：2015
Abnormal lipid metabolism is a common feature in most solid tumours,which occurs in early stage of the tumour progression [1]....
相关搜索：
